Sleep Clinical Trial
Official title:
Impact of Different Types of Higher Dietary Protein Intake on Sleep Quality in Singapore Older Adults
NCT number | NCT05400005 |
Other study ID # | S19 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | February 1, 2022 |
Est. completion date | March 31, 2025 |
Today, insufficient sleep has become a growing global problem. Sleep is essential to health and changes in sleep patterns are a part of the aging process. Inadequate and low-quality sleep also increases the risk for age-related cognitive decline and disease conditions. More importantly, due to COVID-19 health emergency, there is a significant increase of psychological distress and symptoms of mental illness and a worsening of quality of sleep. Therefore, there is an urgent need to investigate the way of improving sleep quality, in particular during and post COVID-19 period, in older adults. One of the possible strategies in improving sleep quality with lifestyle modification is having higher-protein diet. However, this effect has not been fully elucidated in older adults. In addition, the effect of type of dietary protein on sleep quality is inconclusive and there is no clinical trial which assessed the differential response in sleep quality between animal-sourced protein vs. plant-sourced protein. Therefore, the purpose of this research project is to assess the impact of different types of higher dietary protein intake on sleep quality in Singapore older adults. Findings from the proposed research will provide the scientific evidence of the beneficial effects of regularly consuming higher-protein diet on sleep quality in Singapore older adults. In addition, this research may validate the differential effect of different type of dietary protein on sleep quality. The results from the proposed research will also assist a practical guidance of nutritional behaviour changes providing sleep promoting effects to a large proportion of the Singapore population.
Status | Recruiting |
Enrollment | 54 |
Est. completion date | March 31, 2025 |
Est. primary completion date | August 31, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years to 85 Years |
Eligibility | Inclusion Criteria: 1. Adults 60-85 years old 2. Not following HPB diet Exclusion Criteria: 1. Weight change > 3kg in the past 3 months 2. Exercise vigorously over the past 3 months 3. Drinking more than 2 alcoholic drinks per day 4. (if applicable) Pre-menopausal women 5. Taking dietary supplements or medications which may impact sleep outcomes (e.g. Nutritional Shakes (e.g. Ensure), Trp, 5-HTP or melatonin supplementations) the past 1 month 6. Taking dietary supplements which may impact the gut microbiota (e.g. antibiotics, prebiotics, probiotics) the past 2 months (a list of fermented foods) 7. Impaired renal function (normal values: estimated glomerular filtration rate = 90 mL/min/1.73 m2 calculated by chronic kidney disease epidemiology collaboration equation; CKD EPI) 8. Soy intolerance and/or allergy or any medical conditions that may be affected by consumption of soy products (e.g. gout) 9. Prescribed and taking antihypertensive/cholesterol-lowering/ type-2 diabetic medication or Chinese medicine herb which started less than 3 years prior to the intervention participation 10. Diagnosed with gut/gastrointestinal issues such as lactose intolerance and irritable bowel syndrome (IBS) |
Country | Name | City | State |
---|---|---|---|
Singapore | National University of Singapore | Singapore |
Lead Sponsor | Collaborator |
---|---|
National University of Singapore |
Singapore,
Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep. 2010 May;33(5):585-92. doi: 10.1093/sleep/33.5.585. — View Citation
Saidi O, Rochette E, Dore E, Maso F, Raoux J, Andrieux F, Fantini ML, Merlin E, Pereira B, Walrand S, Duche P. Randomized Double-Blind Controlled Trial on the Effect of Proteins with Different Tryptophan/Large Neutral Amino Acid Ratios on Sleep in Adolescents: The PROTMORPHEUS Study. Nutrients. 2020 Jun 24;12(6):1885. doi: 10.3390/nu12061885. — View Citation
St-Onge MP, Crawford A, Aggarwal B. Plant-based diets: Reducing cardiovascular risk by improving sleep quality? Curr Sleep Med Rep. 2018 Mar;4(1):74-78. Epub 2018 Feb 5. — View Citation
Sutanto CN, Wang MX, Tan D, Kim JE. Association of Sleep Quality and Macronutrient Distribution: A Systematic Review and Meta-Regression. Nutrients. 2020 Jan 2;12(1):126. doi: 10.3390/nu12010126. — View Citation
Zhou J, Kim JE, Armstrong CL, Chen N, Campbell WW. Higher-protein diets improve indexes of sleep in energy-restricted overweight and obese adults: results from 2 randomized controlled trials. Am J Clin Nutr. 2016 Mar;103(3):766-74. doi: 10.3945/ajcn.115.124669. Epub 2016 Feb 10. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in sleep quality assessed by validated sleep questionnaires | Pittsburgh Sleep Quality Index Questionnaire (PSQI) will be used to assess the sleep quality. Overall score ranging from 0 to 21 points, where lower scores denote a healthier sleep quality. | Every 4 weeks (week 0, week 4, week 8, week 12 and week 16) | |
Primary | Change in sleep quality assessed by electronic equipment | An electronic equipment, actigraphy, will be used to assess the sleep quality, including sleep timing and wake up timing. | Every 4 weeks (week 0, week 4, week 8, week 12 and week 16) | |
Primary | Change in blood amino acid concentration | Amino acid concentration in the blood will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Primary | Change in blood serotonin concentration | Serotonin concentration in the blood will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Primary | Change in urinary 6-sulfatoxymelatonin (aMT6s) concentration | 6-sulfatoxymelatonin (aMT6s) concentration in the urine samples will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in fecal microbiome composition | High-throughput sequencing method (using Illumina MiSeq platforms) will be used to assess the changes in gut microbiome composition | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in fecal short chain fatty acid (SCFA) concentration | SCFA concentration in fecal samples will be measured. | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in serum lipopolysaccharide binding protein (LBP) concentration | LBP concentration in blood samples will be measured. | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in blood short chain fatty acid (SCFA) concentration | SCFA concentration in the blood will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in fecal bile acids | Bile acids concentration will be determined from fecal samples of the subjects | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in fecal zonulin | Zonulin concentration will be determined from fecal samples of the subjects | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in fecal calprotectin | Calprotectin concentration will be determined from fecal samples of the subjects | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in urinary creatinine concentration | Creatinine concentration in the urine samples will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in Estimated Glomerular Filtration Rate (eGFR) | The estimated Glomerular Filtration Rate (eGFR) of the subjects will be measured from the blood | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in Trimethylamine N-oxide (TMAO) | Trimethylamine N-oxide (TMAO) concentration in the blood will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in Blood Glucose | Glucose concentration in the blood will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in Blood Triglyceride | Triglyceride concentration in the blood will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in Blood Cholesterol | Total cholesterol concentration in the blood will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in Blood Low-density Lipoprotein-cholesterol (LDL) | LDL concentration in the blood will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in Blood High-density Lipoprotein-cholesterol (LDL) | HDL concentration in the blood will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in Blood Advanced Glycation End-product (AGEs) | AGEs concentration in the blood will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in Skin Advanced Glycation End-product (AGEs) | Using a scanner, the AGEs levels in the skin will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in Blood Interleukin-6 (IL-6) | Interleukin-6 (IL-6) concentration in the blood will be measured | Every 8 weeks (week 0 , week 8 and week 16) | |
Secondary | Change in Endothelial Function | Endothelial functions are determined by the function of endothelial progenitor cells | Baseline and Post-intervention (week 0 and week 16) | |
Secondary | Change in Flow Mediate Dilation | Flow mediate dilation (%) | Baseline and Post-intervention (week 0 and week 16) | |
Secondary | Change in weight and height | Weight (in kilograms) and height (in meters) will be combined to report BMI in kg/m^2 | Every 4 weeks (week 0, week 4, week 8, week 12 and week 16) | |
Secondary | Change in waist circumference | Waist circumference (in cm) will be measured | Every 4 weeks (week 0, week 4, week 8, week 12 and week 16) | |
Secondary | Change in blood pressure | Systolic and diastolic blood pressure (in mmHg) will be measured by a blood pressure monitor. | Every 4 weeks (week 0, week 4, week 8, week 12 and week 16) | |
Secondary | Dietary assessment | Dietary assessment will be assessed by 3-day dietary food record | Every 4 weeks (week 0, week 4, week 8, week 12 and week 16) | |
Secondary | Change in mood (stress) | Perceived Stress Scale (PSS) will be used to assess the stress levels | Every 4 weeks (week 0, week 4, week 8, week 12 and week 16) | |
Secondary | Change in mood (depression) | Geriatric Depression Scale (GDS) Assessment will be used to assess the depression status | Every 4 weeks (week 0, week 4, week 8, week 12 and week 16) | |
Secondary | Change in mood (anxiety) | Geriatric Anxiety Inventory (GAI) Assessment will be used to assess the anxiety status. | Every 4 weeks (week 0, week 4, week 8, week 12 and week 16) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Recruiting |
NCT06079853 -
Nurse Suicide: Physiologic Sleep Health Promotion Trial
|
N/A | |
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT04513743 -
Ultra Long-Term Sleep Monitoring Using UNEEG™ Medical 24/7 EEG™ SubQ
|
N/A | |
Completed |
NCT03251274 -
Bath Machine on Sleep Quality in Nursing Home
|
N/A | |
Completed |
NCT04102345 -
Lavender vs Zolpidem Sleep Quality During Diagnostic PSG
|
Early Phase 1 | |
Completed |
NCT03725943 -
Comparison of Dreem to Clinical PSG for Sleep Monitoring in Healthy Adults
|
N/A | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT04562181 -
Consistency Evaluation of the qCON, qNOX Indices and Bispectral Index
|
N/A | |
Completed |
NCT05102565 -
A Dyadic Telehealth Program for Alzheimer's Patients/Caregivers
|
N/A | |
Completed |
NCT05576844 -
Ai Youmian (Love Better Sleep) for People Living With HIV
|
N/A | |
Completed |
NCT04688099 -
Synovial Fluid Sleep Study
|
||
Recruiting |
NCT04171245 -
Prescribing Laughter for Sleep and Wellbeing in UAE University Students
|
N/A | |
Completed |
NCT03758768 -
The Effects of a Blue Monochromatic Light Intervention on Evening-type Individuals' Sleep and Circadian Rhythms
|
N/A | |
Completed |
NCT03163498 -
Evaluation of Sleep Pattern and Mood Profile in Hypertensive Patients
|
||
Completed |
NCT04093271 -
Investigating the Efficacy of Rest-ZZZ Formula in Healthy Participants With Difficulty Falling Asleep or Staying a Sleep
|
Phase 1 | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Completed |
NCT04120363 -
Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations
|
Phase 4 |